Merck & Co Current Assets
The Current Assets of Merck & Co (MRK) as of Sep 10, 2026 is 30.71 B USD. In the previous year, Current Assets was 39.62 B USD — a change of -22.49% (lower).
Get this data via API
Financial Data API
Current Assets
30.71 BUSD
YoY
-22.49%
Last updated:
The Merck & Co Current Assets history
3 Years
10 Years
25 Years
Max
| YEAR | Current Assets | YoY |
|---|---|---|
| 30.71 BUSD | -22.49% | |
| 39.62 BUSD | +20.47% | |
| 32.89 BUSD | -9.60% | |
| 36.38 BUSD | +20.21% | |
| 30.27 BUSD | +5.05% | |
| 28.81 BUSD | +4.84% | |
| 27.48 BUSD | +6.21% | |
| 25.88 BUSD | +4.48% | |
| 24.77 BUSD | -19.10% | |
| 30.61 BUSD | +2.90% | |
| 29.75 BUSD | -8.75% | |
| 32.61 BUSD | -8.63% | |
| 35.69 BUSD | +1.50% | |
| 35.16 BUSD | +5.09% | |
| 33.46 BUSD | +13.75% | |
| 29.41 BUSD | +2.23% | |
| 28.77 BUSD | +45.78% | |
| 19.74 BUSD | +25.84% | |
| 15.68 BUSD | +2.97% | |
| 15.23 BUSD | -27.65% | |
| 21.05 BUSD | +56.21% | |
| 13.48 BUSD | +16.90% | |
| 11.53 BUSD | -19.87% | |
| 14.39 BUSD | +10.99% | |
| 12.96 BUSD | -4.68% | |
| 13.60 BUSD | +20.77% | |
| 11.26 BUSD | +10.08% | |
| 10.23 BUSD | +24.54% | |
| 8.21 BUSD | +6.30% | |
| 7.73 BUSD | -10.34% | |
| 8.62 BUSD | +37.75% | |
| 6.26 BUSD | +24.58% | |
| 5.02 BUSD | +14.14% | |
| 4.40 BUSD | +2.06% | |
| 4.31 BUSD | +14.46% | |
| 3.77 BUSD | +10.46% | |
| 3.41 BUSD | +0.60% | |
| 3.39 BUSD | +12.72% | |
| 3.01 BUSD | +19.73% | |
| 2.51 BUSD | +8.71% | |
| 2.31 BUSD | +6.01% | |
| 2.18 BUSD | +25.75% | |
| 1.73 BUSD | — |
Merck & Co Stock analysis
Frequently Asked Questions about Merck & Co stock
Current Assets of Merck & Co is 30.71 B USD in 2026.
Current Assets of Merck & Co changed from 39.62 B USD to 30.71 B USD, representing a -22.49% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Assets Merck & Co since 2006 – with annual values, charts, and detailed analysis.
Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.
Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Merck & Co historically and in real time.
Balance Sheet — Merck & Co
All Key Metrics — Merck & Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth